TY - JOUR
T1 - Role of glucocorticoid-induced leucine zipper (GILZ) in bone acquisition
AU - Pan, Guodong
AU - Cao, Jay
AU - Yang, Nianlan
AU - Ding, Kehong
AU - Fan, Cheng
AU - Xiong, Wen Cheng
AU - Hamrick, Mark
AU - Isales, Carlos M.
AU - Shi, Xing Ming
PY - 2014/7/11
Y1 - 2014/7/11
N2 - Glucocorticoids (GCs) have both anabolic and catabolic effects on bone. However, no GC anabolic effect mediator has been identified to date. Here we show that targeted expression of glucocorticoid-induced leucine zipper (GILZ), a GC anti-inflammatory effect mediator, enhances bone acquisition in mice. Transgenic mice, in which the expression of GILZ is under the control of a 3.6-kb rat type I collagen promoter, exhibited a high bone mass phenotype with significantly increased bone formation rate and osteoblast numbers. The increased osteoblast activity correlates with enhanced osteogenic differentiation and decreased adipogenic differentiation of bone marrow stromal cell cultures in vitro. In line with these changes, them RNA levels of key osteogenic regulators (Runx2 and Osx) increased, and the level of adipogenic regulator peroxisome proliferator-activated receptor (PPAR) γ2 decreased significantly. We also found that GILZ physically interacts with C/EBPs and disrupts C/EBP-mediated PPARγ gene transcription. In conclusion, our results showed that GILZ is capable of increasing bone acquisition in vivo, and this action is mediated via a mechanism involving the inhibition of PPARγ gene transcription and shifting of bone marrow MSC/progenitor cell lineage commitment in favor of the osteoblast pathway.
AB - Glucocorticoids (GCs) have both anabolic and catabolic effects on bone. However, no GC anabolic effect mediator has been identified to date. Here we show that targeted expression of glucocorticoid-induced leucine zipper (GILZ), a GC anti-inflammatory effect mediator, enhances bone acquisition in mice. Transgenic mice, in which the expression of GILZ is under the control of a 3.6-kb rat type I collagen promoter, exhibited a high bone mass phenotype with significantly increased bone formation rate and osteoblast numbers. The increased osteoblast activity correlates with enhanced osteogenic differentiation and decreased adipogenic differentiation of bone marrow stromal cell cultures in vitro. In line with these changes, them RNA levels of key osteogenic regulators (Runx2 and Osx) increased, and the level of adipogenic regulator peroxisome proliferator-activated receptor (PPAR) γ2 decreased significantly. We also found that GILZ physically interacts with C/EBPs and disrupts C/EBP-mediated PPARγ gene transcription. In conclusion, our results showed that GILZ is capable of increasing bone acquisition in vivo, and this action is mediated via a mechanism involving the inhibition of PPARγ gene transcription and shifting of bone marrow MSC/progenitor cell lineage commitment in favor of the osteoblast pathway.
UR - http://www.scopus.com/inward/record.url?scp=84904161403&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84904161403&partnerID=8YFLogxK
U2 - 10.1074/jbc.M113.535237
DO - 10.1074/jbc.M113.535237
M3 - Article
C2 - 24860090
AN - SCOPUS:84904161403
SN - 0021-9258
VL - 289
SP - 19373
EP - 19382
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 28
ER -